Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 5, 2006, Pages 736-741

  Boodhwani, Munir ^a   Feng, Jun ^a   Mieno, Shigetoshi ^a   Ramlawi, Basel ^a   Sodha, Neel ^a   Clements, Richard ^a   Sellke, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Biomaterials; CABG; Coronary artery bypass grafts; Endothelium; Off pump

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITROPRUSSIDE SODIUM; POLOXAMER; PROTEIN BAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL OCCLUSION; CLAMP; CONCENTRATION (PARAMETERS); CORONARY ARTERY; CORRELATION COEFFICIENT; GEL; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE PRESSURE; IN VITRO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; STERNOTOMY; SWINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CONSTRICTION; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GELS; POLOXAMER; SWINE; VASODILATION; VENTRICULAR FUNCTION, LEFT;

EID: 33646086020     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.02.024     Document Type: Article

References (17)

1. Al-Ruzzeh S., Ambler G., Asimakopoulos G., Omar R.Z., Hasan R., Fabri B., El-Gamel A., DeSouza A., Zamvar V., Griffin S., Keenan D., Trivedi U., Pullan M., Cale A., Cowen M., Taylor K., and Amrani M. Off-pump coronary artery bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: a United Kingdom multi-center comparative analysis of early clinical outcome. Circulation 108 Suppl. 1 (2003) II1-II8
2. Boodhwani M., Cohn W.E., Feng J., Ramlawi B., Mieno S., Schwarz A., and Sellke F.W. Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery. Ann Thorac Surg 80 6 (2005) 2333-2337
3. Qiu Y., and Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 53 (2001) 321-339
4. Khan T.A., Bianchi C., Voisine P., Feng J., Baker J., Hart M., Takahashi M., Stahl G., and Sellke F.W. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 128 (2004) 602-608
5. Ruel M., Wu G.F., Khan T.A., Voisine P., Bianchi C., Li J., Laham R.J., and Sellke F.W. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model. Circulation 108 Suppl. 1 (2003) II335-II340
6. Marcel D. Nonionic surfactants: polyoxyalkylene block copolymers. In: Nace V, editor. Surfactant science series. Marcel Dekker, New York; 1996. p. 280.
7. Maynard C., Swenson R., Paris J.A., Martin J.S., Hallstrom A.P., Cerqueira M.D., and Weaver W.D. Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group. Am Heart J 135 (1998) 797-804
8. O'Keefe J.H., Grines C.L., DeWood M.A., Schaer G.L., Browne K., Magorien R.D., Kalbfleisch J.M., Fletcher Jr. W.O., Bateman T.M., and Gibbons R.J. Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 78 (1996) 747-750
9. Material Safety Data Sheet for Poloxamer 407 (Pluronic F-127): BASF Corporation.
10. Raymond J., Metcalfe A., Salazkin I., and Schwarz A. Temporary vascular occlusion with poloxamer 407. Biomaterials 25 (2004) 3983-3989
11. Perrault L.P., Menasche P., Wassef M., Bidouard J.P., Janiak P., Villeneuve N., Jacquemin C., Bloch G., Vilaine J.P., and Vanhoutte P.M. Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operations. Ann Thorac Surg 62 (1996) 1158-1163
12. Muraki S., Morris C.D., Budde J.M., Otto R.N., Zhao Z.Q., Puskas J.D., Guyton R.A., and Vinten-Johansen J. Preserved myocardial blood flow and oxygen supply-demand balance with active coronary perfusion during simulated off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 123 (2002) 53-62
13. Nollert G., Oberhoffer M., Reichart B., and Vicol C. Combination of the HEARTSTRING proximal seal system with a blower mister: a possible source of gas emboli. J Thorac Cardiovasc Surg 126 (2003) 1192-1194
14. Zhao Z.Q., Nakamura M., Wang N.P., Wilcox J.N., Shearer S., Ronson R.S., Guyton R.A., and Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45 (2000) 651-660
15. Feng J., Bianchi C., Sandmeyer J., Li J., and Sellke F.W. Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegia. Circulation 112 9 Suppl. (2005) 1184-1189
16. Piot C.A., Martini J.F., Bui S.K., and Wolfe C.L. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo. Cardiovasc Res 44 (1999) 536-542
17. Feng J., Bianchi C., Li J., and Sellke F.W. Improved profile of bad phosphorylation and caspase 3 activation after blood versus crystalloid cardioplegia. Ann Thorac Surg 77 (2004) 1384-1389 [discussion 9-90]